Cargando…
Lincp21-RNA as Predictive Response Marker for Preoperative Chemoradiotherapy in Rectal Cancer
Preoperative chemoradiotherapy (CRT) is a standard treatment for locally advanced rectal cancer (RC) patients, but its use in non-responders can be associated with increased toxicities and resection delay. LincRNA-p21 is a long non-coding RNA involved in the p53 pathway and angiogenesis regulation....
Autores principales: | Benitez, Jose Carlos, Campayo, Marc, Díaz, Tania, Ferrer, Carme, Acosta-Plasencia, Melissa, Monzo, Mariano, Cirera, Luis, Besse, Benjamin, Navarro, Alfons |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156811/ https://www.ncbi.nlm.nih.gov/pubmed/34065723 http://dx.doi.org/10.3390/jpm11050420 |
Ejemplares similares
-
miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer
por: Campayo, Marc, et al.
Publicado: (2018) -
LincRNA-p21 Levels Relates to Survival and Post-Operative Radiotherapy Benefit in Rectal Cancer Patients
por: Li, Yan, et al.
Publicado: (2020) -
Human embryonic mesenchymal lung-conditioned medium promotes differentiation to myofibroblast and loss of stemness phenotype in lung adenocarcinoma cell lines
por: Canals, Jordi, et al.
Publicado: (2022) -
Efficacy of hypofractionated preoperative chemoradiotherapy in rectal cancer
por: Cho, Ick Joon, et al.
Publicado: (2023) -
A review of preoperative chemoradiotherapy for lower rectal cancer
por: Beppu, Naohito, et al.
Publicado: (2018)